Myriad Genetics Names George Daneker Jr., MD, as President a

30.01.2024 - SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) - Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of George Daneker Jr., MD, as President and Chief Clinical Officer of ...

Related Keywords

United States , America , Paulj Diaz , Mark Verratti , Matt Scalo , Exchange Commission , University Of Maryland , Oncology Clinical Program , Loyola College , System Vice President , Medical Director , System Corporate Chief Medical Officer , Formerly Cancer Treatment Centers , Chief Commercial Officer , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , Myriad Genetics Chart , Yriad Genetics Kurs , Yriad Genetics Aktie ,